As clinical studies adopt Oxygen-Enhanced MRI to assess its feasibility in human tumours, it is important for researchers to report any practical complications experienced. We report our practical experience with using both MOLLI and VFA T1 mapping for a recently completed OE-MRI clinical oncology study with the aim that sharing this is helpful to researchers planning to use OE-MRI in clinical oncology. Specifically, we report 4 elements: (1) difference in estimated T1 from each method used (MOLLI and VFA), (2) standard deviation within tumour ROIs, (3) OE-MRI response resulting from either method, and (4) artefacts and practical difficulties encountered.
This abstract and the presentation materials are available to members only; a login is required.